Morgan Stanley’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$653K Sell
120,260
-13,776
-10% -$74.8K ﹤0.01% 5331
2025
Q1
$371K Buy
134,036
+36,760
+38% +$102K ﹤0.01% 5461
2024
Q4
$332K Sell
97,276
-48,405
-33% -$165K ﹤0.01% 5586
2024
Q3
$428K Sell
145,681
-162,224
-53% -$477K ﹤0.01% 5472
2024
Q2
$1.05M Sell
307,905
-536,319
-64% -$1.82M ﹤0.01% 4935
2024
Q1
$2.56M Sell
844,224
-219,200
-21% -$664K ﹤0.01% 4414
2023
Q4
$4.48M Buy
1,063,424
+862,122
+428% +$3.63M ﹤0.01% 4440
2023
Q3
$1.37M Sell
201,302
-339,230
-63% -$2.32M ﹤0.01% 4611
2023
Q2
$5.63M Buy
540,532
+310,280
+135% +$3.23M ﹤0.01% 3683
2023
Q1
$1.6M Sell
230,252
-106,354
-32% -$741K ﹤0.01% 4583
2022
Q4
$2.03M Buy
336,606
+17,311
+5% +$104K ﹤0.01% 4453
2022
Q3
$2.52M Sell
319,295
-5,858
-2% -$46.2K ﹤0.01% 4268
2022
Q2
$4.43M Buy
325,153
+155,996
+92% +$2.12M ﹤0.01% 3872
2022
Q1
$3.32M Buy
169,157
+77,531
+85% +$1.52M ﹤0.01% 4104
2021
Q4
$3.15M Buy
91,626
+23,280
+34% +$799K ﹤0.01% 4199
2021
Q3
$3.73M Buy
68,346
+19,743
+41% +$1.08M ﹤0.01% 4026
2021
Q2
$3.57M Sell
48,603
-4,996
-9% -$367K ﹤0.01% 4120
2021
Q1
$4.9M Buy
53,599
+36,604
+215% +$3.35M ﹤0.01% 3430
2020
Q4
$1.38M Buy
16,995
+7,182
+73% +$582K ﹤0.01% 4451
2020
Q3
$457K Buy
+9,813
New +$457K ﹤0.01% 4695